NIH agrees to review hundreds of denied or shelved grant applications

In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook

Anthony G. Letai’s initiation as the 18th director of the National Cancer Institute wasn’t exactly smooth.

December 05, 2025

FDA releases draft guidance on reducing testing on non-human primates for monoclonal antibodies

FDA issued a draft guidance on Dec. 2, outlining specific product types for which the FDA believes six-month non-human primate toxicity testing can be eliminated or reduced.

UAMS receives $10.5M NIH grant to develop biomarkers through proteomics

The University of Arkansas for Medical Sciences received a $10.5 million NIH grant to develop biomarkers for all human diseases, including cancer, through proteomics.

December 05, 2025

Vol.51 No.44

Cancer Policy

Trump cuts disrupted 383 clinical trials, affecting 74,000 trial participants

Approximately one in 30 NIH-funded clinical trials—and more than 74,000 trial participants—were affected by grant funding disruptions caused by the Trump administration, according to an analysis in JAMA Internal Medicine.

NIH employee placed on leave after openly criticizing Trump

An NIH employee who has been publicly critical of the Trump administration’s health policies said she was placed on “nondisciplinary” administrative leave when she returned to work Nov. 13 after the government reopened.

November 21, 2025

Vol.51 No.43

By Claire Marie Porter